Close Menu

autistic disorder

Jonathan Sebat, chief of the Beyster Center for Molecular Genomics of Neuropsychiatric Diseases at the University of California, San Diego, told GenomeWeb Daily News the center will carry out whole-genome sequencing in families with autism and schizophrenia.

An international consortium has identified rare copy number variants that are more common in individuals on the autism spectrum.

While using stem cells allows Stemina to "make the tissue type of interest. It's an all-human system," and allows the firm to build "the best potential in vitro environment to study a particular question," its CEO said.

The Toronto hospital for children will use the funding to perform genomic sequencing research on autism spectrum disorder patients in order to develop new screening and diagnostic tools.

Part of the autism advocacy organization's latest round of funding will support research aimed at developing protein biomarkers and better animal models.

Three grant types will support clinical, basic, and applied research using genomic and pharmacogenomic approaches, among others.

The company plans to develop and sell an autism risk test for children with older siblings who have already been diagnosed.

According to the grant abstracts, the project is "an unprecedented partnership" between two large-scale sequencing centers — at Baylor College of Medicine and at the Broad Institute — and a network of research labs focused on the genetics of autism, brought together by the Autism Genome Project and the Autism Consortium.

All three projects plan to use high-throughput sequencing to identify variants associated with autism or autism spectrum disorder.

Moving Target: CNVs in Disease

Premium

More and more research is linking CNVs to disease. It's not only changing the way scientists study disease, but also how clinicians diagnose it.

Pages

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.